SCHEMBL6223391

SCHEMBL6223391

CS(=O)(=O)Nc1cccc(NC(=O)c2n[nH]c3ccc(-c4cccnc4)cc23)c1

nearest known ligand 0.68

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 20/20 0.68
▸ WNT1 P04628 12/20 0.68
▸ CLK2 P49760 2/20 0.67
▸ CLK3 P49761 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82928 0.92 DYRK1A (0.71) DYRK1AWNT1CLK2CLK3
SCHEMBL5916105 0.88 DYRK1A (0.59) DYRK1AWNT1CLK2CLK3
SCHEMBL14792517 0.86 DYRK1A (0.70) DYRK1AWNT1CLK2CLK3
SCHEMBL14785604 0.86 DYRK1A (0.84) DYRK1AWNT1CLK2CLK3
SCHEMBL14804108 0.86 DYRK1A (0.81) DYRK1AWNT1CLK2CLK3
SCHEMBL6223964 0.85 DYRK1A (0.78) DYRK1AWNT1CLK2CLK3
SCHEMBL6222250 0.85 DYRK1A (0.71) DYRK1AWNT1CLK2CLK3
SCHEMBL14804581 0.84 DYRK1A (0.71) DYRK1AWNT1CLK2CLK3
SCHEMBL14785680 0.83 DYRK1A (0.70) DYRK1AWNT1CLK2CLK3
SCHEMBL5916060 0.83 DYRK1A (0.59) DYRK1AWNT1CLK2CLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549620-A1 INDAZOLECARBOXAMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS CDK1, CDK2 AND CDK4 INHIBITORS Sanofi-Aventis (FR) 2005-07-06 — — EP claimed
WO-2004031158-A1 INDAZOLECARBOXAMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS CDK1, CDK2 AND CDK4 INHIBITORS SANOFI-AVENTIS (FR) 2004-04-15 — — WO claimed
EP-1549620-A1 INDAZOLECARBOXAMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS CDK1, CDK2 AND CDK4 INHIBITORS Sanofi-Aventis (FR) 2005-07-06 — — EP disclosed
WO-2004031158-A1 INDAZOLECARBOXAMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS CDK1, CDK2 AND CDK4 INHIBITORS SANOFI-AVENTIS (FR) 2004-04-15 — — WO disclosed
Send feedback